Phase 1/1b Study of RMC-6236 in KRAS-Driven Advanced Solid Tumors
Trial Name: Evaluation of RMC-6236 in Subjects With Advanced Solid Tumors Harboring Specific Mutations in KRAS
ClinicalTrials.gov Indentifier: NCT05379985
Completion Date: December 2025
Recruitment Status: Not yet recruiting
Sponsor: Revolution Medicines, Inc.
Contact: inquiries@RevMed.com or (650) 779-2300